Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Corrigendum to "In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways".

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT.

Case Rep Infect Dis. 2019 Sep 2;2019:8314349. doi: 10.1155/2019/8314349. eCollection 2019.

2.

Self-perceived impact of stroke: A longitudinal comparison between one and five years post-stroke.

Skoglund E, Westerlind E, Persson HC, Sunnerhagen KS.

J Rehabil Med. 2019 Oct 4;51(9):660-664. doi: 10.2340/16501977-2595.

3.

Longitudinal Muscle and Myocellular Changes in Community-Dwelling Men Over Two Decades of Successful Aging-The ULSAM Cohort Revisited.

Skoglund E, Grönholdt-Klein M, Rullman E, Thornell LE, Strömberg A, Hedman A, Cederholm T, Ulfhake B, Gustafsson T.

J Gerontol A Biol Sci Med Sci. 2019 Apr 19. pii: glz068. doi: 10.1093/gerona/glz068. [Epub ahead of print]

PMID:
31002330
4.

Economic health care costs of blood culture contamination: A systematic review.

Dempsey C, Skoglund E, Muldrew KL, Garey KW.

Am J Infect Control. 2019 Aug;47(8):963-967. doi: 10.1016/j.ajic.2018.12.020. Epub 2019 Feb 20. Review.

PMID:
30795840
5.

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT.

Case Rep Infect Dis. 2018 Dec 23;2018:9095203. doi: 10.1155/2018/9095203. eCollection 2018. Erratum in: Case Rep Infect Dis. 2019 Sep 2;2019:8314349.

6.

Estimated Clinical and Economic Impact through Use of a Novel Blood Collection Device To Reduce Blood Culture Contamination in the Emergency Department: a Cost-Benefit Analysis.

Skoglund E, Dempsey CJ, Chen H, Garey KW.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01015-18. doi: 10.1128/JCM.01015-18. Print 2019 Jan.

7.

Significant Publications on Infectious Diseases Pharmacotherapy in 2017.

Skoglund EW, Dotson KM, Dempsey CJ, Su CP, Foolad F, Janak C, Sofjan AK, Phe K.

J Pharm Pract. 2019 Oct;32(5):534-545. doi: 10.1177/0897190018792797. Epub 2018 Aug 13.

PMID:
30099951
8.

Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.

McLaughlin MM, Miglis C, Skoglund E, Wagner J, Advincula MR, Scheetz MH.

J Glob Antimicrob Resist. 2018 Jun;13:261-263. doi: 10.1016/j.jgar.2018.02.003. Epub 2018 Feb 9.

PMID:
29432939
9.

Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates.

Skoglund E, Ledesma KR, Lasco TM, Tam VH.

J Glob Antimicrob Resist. 2017 Dec;11:154-155. doi: 10.1016/j.jgar.2017.10.016. Epub 2017 Oct 31. No abstract available.

PMID:
29101084
10.

Significant Publications on Infectious Diseases Pharmacotherapy in 2016.

Fong G, Skoglund EW, Phe K, Guastadisegni J, Shea KM, McDaneld PM, Perez KK, Sofjan AK.

J Pharm Pract. 2018 Oct;31(5):469-480. doi: 10.1177/0897190017727212. Epub 2017 Aug 29. Review.

PMID:
28847232
11.

Prediction of inventory sustainability during a drug shortage.

Rhodes NJ, Gilbert EM, Skoglund E, Esterly JS, Postelnick MJ, McLaughlin MM.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1094-8. doi: 10.2146/ajhp150532.

PMID:
27385704
12.

Development of a pharmacy student research program at a large academic medical center.

McLaughlin MM, Skoglund E, Bergman S, Scheetz MH.

Am J Health Syst Pharm. 2015 Nov 1;72(21):1885-9. doi: 10.2146/ajhp150042.

PMID:
26490823
13.

Peramivir: an intravenous neuraminidase inhibitor.

McLaughlin MM, Skoglund EW, Ison MG.

Expert Opin Pharmacother. 2015;16(12):1889-900. doi: 10.1517/14656566.2015.1066336. Epub 2015 Jul 8. Review.

PMID:
26153242
14.

Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.

D'Agostino C, Rhodes NJ, Skoglund E, Roberts JA, Scheetz MH.

J Infect Chemother. 2015 Oct;21(10):742-6. doi: 10.1016/j.jiac.2015.05.010. Epub 2015 Jun 9.

PMID:
26143049
15.

Drug shortages and patient safety: an overview of essential information for the infusion nurse.

McLaughlin MM, Skoglund EW.

J Infus Nurs. 2015 May-Jun;38(3):205-8. doi: 10.1097/NAN.0000000000000101.

PMID:
25871867
16.

Projections for antiinfective drug shortages and time to actual resolution.

McLaughlin MM, Pentoney Z, Skoglund E, Scheetz MH.

Am J Health Syst Pharm. 2014 Dec 1;71(23):2074-8. doi: 10.2146/ajhp140116.

PMID:
25404600
17.

Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages.

McLaughlin MM, Skoglund E, Pentoney Z, Scheetz MH.

Infect Dis Ther. 2014 Dec;3(2):349-55. doi: 10.1007/s40121-014-0040-z. Epub 2014 Sep 19.

18.

[Physicians to the people].

Skoglund E.

Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1847-50. doi: 10.4045/tidsskr.13.0867. Norwegian. No abstract available.

19.

[Who was the district general practitioner Johnsen?].

Hem E, Skoglund E.

Tidsskr Nor Laegeforen. 2009 Aug 13;129(15):1485. doi: 10.4045/tidsskr.09.0754. Norwegian. No abstract available.

20.

[History of specialist education].

Skoglund E.

Tidsskr Nor Laegeforen. 2009 May 28;129(11):1124-7. doi: 10.4045/tidsskr.09.0432. Norwegian. No abstract available.

21.

Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.

Briem S, Martinsson S, Bueters T, Skoglund E.

Rapid Commun Mass Spectrom. 2007;21(13):1965-72.

PMID:
17526069
22.

Congener-specific accumulation and patterns of chlorinated and brominated contaminants in adult male walruses from Svalbard, Norway: indications for individual-specific prey selection.

Wolkers H, van Bavel B, Ericson I, Skoglund E, Kovacs KM, Lydersen C.

Sci Total Environ. 2006 Oct 15;370(1):70-9. Epub 2006 Aug 17.

PMID:
16916533
23.

[Role of the Medical Society in medical education and competence development].

Fredriksen A, Hoftvedt BO, Holm HA, Skoglund E.

Tidsskr Nor Laegeforen. 2006 Jan 5;126(1):78-81. Norwegian. No abstract available.

24.

[Norwegian-Swedish labor market for physicians].

Skoglund E, Taraldset A, Holm HA.

Tidsskr Nor Laegeforen. 2005 Jun 2;125(11):1511-2. Norwegian. No abstract available.

25.

Description and validation of a four-channel staggered LC-MS/MS system for high-throughput in vitro screens.

Briem S, Pettersson B, Skoglund E.

Anal Chem. 2005 Mar 15;77(6):1905-10.

PMID:
15762603
26.

Generic three-column parallel LC-MS/MS system for high-throughput in vitro screens.

Lindqvist A, Hilke S, Skoglund E.

J Chromatogr A. 2004 Nov 26;1058(1-2):121-6.

PMID:
15595659
27.

[Development of postgraduate medical education in Norway].

Aasved H, Skoglund E.

Tidsskr Nor Laegeforen. 2004 Aug 26;124(16):2116-7. Norwegian.

28.

[Stimulation measures mean professional boost for physicians in remote areas].

Fredriksen A, Skoglund E.

Tidsskr Nor Laegeforen. 2003 Nov 6;123(21):1p following 3069. Norwegian. No abstract available.

PMID:
14650393
29.

Rapid analysis of inositol phosphates.

Carlsson NG, Bergman EL, Skoglund E, Hasselblad K, Sandberg AS.

J Agric Food Chem. 2001 Apr;49(4):1695-701.

PMID:
11308312
30.

[Continuing education in the Nordic countries].

Oien IJ, Skoglund E.

Tidsskr Nor Laegeforen. 2000 Jun 30;120(17):2035-7. Norwegian.

31.

[The manpower market for physicians in the Nordic countries 1980-2000].

Skoglund E, Taraldset A.

Tidsskr Nor Laegeforen. 2000 Jun 30;120(17):2030-4. Norwegian.

32.

Inositol phosphates influence iron uptake in Caco-2 cells.

Skoglund E, Lönnerdal B, Sandberg AS.

J Agric Food Chem. 1999 Mar;47(3):1109-13.

PMID:
10552423
33.

Inositol phosphates with different numbers of phosphate groups influence iron absorption in humans.

Sandberg AS, Brune M, Carlsson NG, Hallberg L, Skoglund E, Rossander-Hulthén L.

Am J Clin Nutr. 1999 Aug;70(2):240-6.

PMID:
10426701
34.

[Re-certification of specialists in Norway].

Skoglund E.

Nord Med. 1998 Jan;113(1):27-8. Norwegian. No abstract available.

PMID:
9465705
35.

[Unlimited demand for specialists?].

Skoglund E.

Tidsskr Nor Laegeforen. 1996 Nov 20;116(28):3321-2. Norwegian. No abstract available.

PMID:
9011986
36.

[Internship during continuing education should be prioritized].

Gerner T, Grøttum K, Schreiner A, Olen IJ, Skoglund E.

Tidsskr Nor Laegeforen. 1996 Aug 30;116(20):2500-1. Norwegian. No abstract available.

PMID:
8928117
37.

[Mutual evaluation of teaching hospital departments. A way to improve the quality of specialist education].

Brinchmann-Hansen A, Hoftvedt BO, Oien IJ, Skoglund E.

Tidsskr Nor Laegeforen. 1996 Aug 10;116(18):2180-2. Norwegian.

PMID:
8801662
38.

[Apply the children's convention also to refugees].

Skoglund E.

Lakartidningen. 1994 Nov 16;91(46):4235-6. Swedish. No abstract available.

PMID:
7808116
39.

Quality of poststressor rest influences the ulcerative process.

Overmier JB, Murison R, Ursin H, Skoglund EJ.

Behav Neurosci. 1987 Apr;101(2):246-53.

PMID:
3580127
40.

[Physicians' continuing and postgraduate education. Specialty education--from collegial advertisement stories to law-based specialist competence].

Skoglund E.

Tidsskr Nor Laegeforen. 1986 May 25;106(14):1220-6. Norwegian. No abstract available.

PMID:
3750285
41.
42.

Regulation of animal experimentation in Sweden.

Skoglund E.

Acta Physiol Scand. 1986;128(Suppl. 554):153-7. No abstract available.

PMID:
11649994
43.

Regulation of animal experimentation in Sweden.

Skoglund E.

Acta Physiol Scand Suppl. 1986;554:153-7.

PMID:
3469872
44.

[We should work towards coordination of postgraduate training for doctors in the Scandinavian countries].

Skoglund E.

Nord Med. 1981 May;96(5):148-9. Norwegian. No abstract available.

PMID:
7243559
45.

ACETYLENIC DERIVATIVES OF 2,4(1H,3H)-QUINAZOLINEDIONE.

DANIELSSON B, SKOGLUND E.

Acta Pharm Suec. 1965 Apr;2:167-74. No abstract available.

PMID:
14323470
46.

[Medical genetics].

SKOGLUND E.

Sven Lakartidn. 1959 Feb 6;56(6):345-54. Swedish. No abstract available.

PMID:
13647247
47.

Gerstmann-syndromet.

SKOGLUND E, SODERLING B.

Nord Med. 1957 Dec 12;58(50):1928-30. Swedish. No abstract available.

PMID:
13504552
48.

[Evaluation of the fetus as a human].

SKOGLUND E.

Sven Lakartidn. 1953 Apr 17;50(16):868-73. Undetermined Language. No abstract available.

PMID:
13077296
49.

[The patient and his forgotten soul; from the conference of physicians, nurses and clergymen, Ostersund, June 14-18, 1952].

SKOGLUND E.

Sven Lakartidn. 1952 Oct 3;49(40):2495-7. Undetermined Language. No abstract available.

PMID:
13028909

Supplemental Content

Loading ...
Support Center